Psilocybin group therapy shows promise for PTSD in early trial
NCT ID NCT07506395
First seen Apr 02, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This early-stage study tests whether psilocybin-assisted therapy in a group setting is safe and feasible for people with PTSD. About 36 adults, including veterans, first responders, female survivors of sexual violence, and Indigenous people, will receive the treatment. The goal is to see if it helps reduce PTSD symptoms and is well-tolerated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTSD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Interdisciplinary Substance Use and Brain Injury (ISUBI)
RECRUITINGAlbuquerque, New Mexico, 87131, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.